Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus

Arch Physiol Biochem. 2022 Aug;128(4):910-913. doi: 10.1080/13813455.2020.1739714. Epub 2020 Mar 19.

Abstract

Objective: We aimed to determine myo-inositol oxygenase (MIOX) activity in gestational diabetes mellitus (GDM).

Material and methods: The insulin, HbA1c, and MIOX levels of 80 pregnant women were analysed after 75 g OGTT. Group I included patients with no risk factor for GDM, Group II: patients with high risk for GDM, and Group III: GDM patients.

Results: Fasting plasma glucose and Homeostatic Model Assessment for Insulin Resistance index were significantly higher in GDM cases (Group 3). Regarding the MIOX levels, significantly higher levels were recorded at 0-h in Group 3 compared to Groups 1 and 2. Significant alteration in MIOX activity was found between 0- and 2-h in Group 3 compared to Groups 1 and 2 (p < .029).

Conclusions: MIOX levels were higher in GDM cases so, it may be have a role in myo-inositol catabolism.

Keywords: Serum Myo-inositol oxygenase; gestational diabetes mellitus; second trimester.

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes, Gestational*
  • Female
  • Humans
  • Inositol
  • Inositol Oxygenase*
  • Insulin
  • Insulin Resistance*
  • Pregnancy
  • Pregnancy Trimester, Second

Substances

  • Blood Glucose
  • Insulin
  • Inositol
  • Inositol Oxygenase